Arshi Armin, Sharim Justin, Park Don Y, Park Howard Y, Bernthal Nicholas M, Yazdanshenas Hamed, Shamie Arya N
Department of Orthopedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA.
Spine (Phila Pa 1976). 2017 May 1;42(9):644-652. doi: 10.1097/BRS.0000000000001870.
Retrospective analysis.
To determine the epidemiology and prognostic indicators in patients with chondrosarcoma of the osseous spine.
Chondrosarcoma of the spine is rare, with limited data on its epidemiology, clinicopathologic features, and treatment outcomes. Therapy centers on complete en bloc resection with radiotherapy reserved for subtotal resection or advanced disease.
The Surveillance, Epidemiology, and End Results Registry was queried for patients with chondrosarcoma of the osseous spine from 1973 to 2012. Study variables included age, sex, race, year of diagnosis, size, grade, extent of disease, and treatment modality.
The search identified 973 cases of spinal chondrosarcoma. Mean age at diagnosis was 51.6 years, and 627% of patients were males. Surgical resection and radiotherapy were performed in 75.2% and 21.3% of cases, respectively. Kaplan-Meier analysis demonstrated overall survival (OS) and disease-specific survival (DSS) of 53% and 64%, respectively, at 5 years. Multivariate Cox regression analysis showed that age (OS, P < 0.001; DSS, P = 0.007), grade (OS, P < 0.001; DSS, P < 0.001), surgical resection (OS, P < 0.001; DSS, P < 0.001), and extent of disease (OS, P < 0.001; DSS, P < 0.001) were independent survival determinants; tumor size was an independent predictor of OS (P = 0.006). For confined disease, age (P = 0.013), decade of diagnosis (P = 0.023), and surgery (P = 0.017) were independent determinants of OS. For locally invasive disease, grade (OS, P < 0.001; DSS, P = 0.003), surgery (OS, P = 0.013; DSS, P = 0.046), and size (OS, P = 0.001, DSS, P = 0.002) were independent determinants of OS and DSS. Radiotherapy was an independent indicator of worse OS for both confined (P = 0.004) and locally invasive disease (P = 0.002). For metastatic disease, grade (OS, P = 0.021; DSS, P = 0.012) and surgery (OS, P = 0.007; DSS, P = 0.004) were survival determinants for both OS and DSS, whereas radiotherapy predicted improved OS (P = 0.039).
Surgical resection confers survival benefit in patients with chondrosarcoma of the spine independent of extent of disease. Radiotherapy improves survival in patients with metastatic disease and worsens outcomes in patients with confined and locally invasive disease.
回顾性分析。
确定脊柱骨肉瘤患者的流行病学特征和预后指标。
脊柱骨肉瘤较为罕见,关于其流行病学、临床病理特征及治疗结果的数据有限。治疗以整块切除为主,放疗用于次全切除或晚期疾病。
查询监测、流行病学和最终结果登记处1973年至2012年脊柱骨肉瘤患者的数据。研究变量包括年龄、性别、种族、诊断年份、肿瘤大小、分级、疾病范围及治疗方式。
检索到973例脊柱骨肉瘤病例。诊断时的平均年龄为51.6岁,62.7%为男性。分别有75.2%和21.3%的病例接受了手术切除和放疗。Kaplan-Meier分析显示,5年总生存率(OS)和疾病特异性生存率(DSS)分别为53%和64%。多因素Cox回归分析表明,年龄(OS,P<0.001;DSS,P=0.007)、分级(OS,P<0.001;DSS,P<0.001)、手术切除(OS,P<0.001;DSS,P<0.001)及疾病范围(OS,P<0.001;DSS,P<0.001)是独立的生存决定因素;肿瘤大小是OS的独立预测因素(P=0.006)。对于局限性疾病,年龄(P=0.013)、诊断年代(P=0.023)及手术(P=0.017)是OS的独立决定因素。对于局部侵袭性疾病,分级(OS,P<0.001;DSS,P=0.003)、手术(OS,P=0.013;DSS,P=0.046)及大小(OS,P=0.001,DSS,P=0.002)是OS和DSS的独立决定因素。放疗是局限性疾病(P=0.004)和局部侵袭性疾病(P=0.002)OS较差的独立指标。对于转移性疾病,分级(OS,P=0.021;DSS,P=0.012)和手术(OS,P=0.007;DSS,P=0.004)是OS和DSS的生存决定因素,而放疗可改善OS(P=0.039)。
手术切除可使脊柱骨肉瘤患者获得生存益处,与疾病范围无关。放疗可改善转移性疾病患者的生存,但会使局限性和局部侵袭性疾病患者的预后恶化。
4级。